Literature DB >> 28462820

Short DNA Hairpins Compromise Recombinant Adeno-Associated Virus Genome Homogeneity.

Jun Xie1, Qin Mao2, Phillip W L Tai3, Ran He4, Jianzhong Ai5, Qin Su4, Ye Zhu6, Hong Ma4, Jia Li7, Shoufang Gong7, Dan Wang3, Zhen Gao7, Mengxin Li4, Li Zhong7, Heather Zhou8, Guangping Gao9.   

Abstract

Short hairpin (sh)RNAs delivered by recombinant adeno-associated viruses (rAAVs) are valuable tools to study gene function in vivo and a promising gene therapy platform. Our data show that incorporation of shRNA transgenes into rAAV constructs reduces vector yield and produces a population of truncated and defective genomes. We demonstrate that sequences with hairpins or hairpin-like structures drive the generation of truncated AAV genomes through a polymerase redirection mechanism during viral genome replication. Our findings reveal the importance of genomic secondary structure when optimizing viral vector designs. We also discovered that shDNAs could be adapted to act as surrogate mutant inverted terminal repeats (mTRs), sequences that were previously thought to be required for functional self-complementary AAV vectors. The use of shDNAs as artificial mTRs opens the door to engineering a new generation of AAV vectors with improved potency, genetic stability, and safety for both preclinical studies and human gene therapy. Published by Elsevier Inc.

Entities:  

Keywords:  adeno-associated virus; genome homogeneity; replication template switching; self-complementary AAV; short hairpin DNA; short hairpin RNA; viral genome truncation

Mesh:

Substances:

Year:  2017        PMID: 28462820      PMCID: PMC5474962          DOI: 10.1016/j.ymthe.2017.03.028

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  45 in total

1.  Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.

Authors:  X Xiao; J Li; R J Samulski
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

2.  Induction of hepatocellular carcinoma by in vivo gene targeting.

Authors:  Pei-Rong Wang; Mei Xu; Sara Toffanin; Yi Li; Josep M Llovet; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

Review 3.  Recombinant AAV as a platform for translating the therapeutic potential of RNA interference.

Authors:  Florie Borel; Mark A Kay; Christian Mueller
Journal:  Mol Ther       Date:  2013-12-19       Impact factor: 11.454

4.  Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correction.

Authors:  Li Zhong; Nirav Malani; Mengxin Li; Troy Brady; Jun Xie; Peter Bell; Shaoyong Li; Haven Jones; James M Wilson; Terence R Flotte; Frederic D Bushman; Guangping Gao
Journal:  Hum Gene Ther       Date:  2013-05       Impact factor: 5.695

5.  Molecular structure of adeno-associated virus variant DNA.

Authors:  L M de la Maza; B J Carter
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

Review 6.  Integration of adeno-associated virus (AAV) and recombinant AAV vectors.

Authors:  Douglas M McCarty; Samuel M Young; R Jude Samulski
Journal:  Annu Rev Genet       Date:  2004       Impact factor: 16.830

7.  Assessing the potential for AAV vector genotoxicity in a murine model.

Authors:  Hojun Li; Nirav Malani; Shari R Hamilton; Alexander Schlachterman; Giulio Bussadori; Shyrie E Edmonson; Rachel Shah; Valder R Arruda; Federico Mingozzi; J Fraser Wright; Frederic D Bushman; Katherine A High
Journal:  Blood       Date:  2010-11-24       Impact factor: 22.113

8.  Rep-mediated nicking of the adeno-associated virus origin requires two biochemical activities, DNA helicase activity and transesterification.

Authors:  J R Brister; N Muzyczka
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

9.  Adeno-associated virus general transduction vectors: analysis of proviral structures.

Authors:  S K McLaughlin; P Collis; P L Hermonat; N Muzyczka
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  Hairpin-end conformation of adeno-associated virus genome determines interactions with DNA-repair pathways.

Authors:  M P Cataldi; D M McCarty
Journal:  Gene Ther       Date:  2012-11-15       Impact factor: 5.250

View more
  25 in total

1.  Effective and Accurate Gene Silencing by a Recombinant AAV-Compatible MicroRNA Scaffold.

Authors:  Jun Xie; Phillip W L Tai; Alexander Brown; Shoufang Gong; Sha Zhu; Yi Wang; Chengjian Li; Cansu Colpan; Qin Su; Ran He; Hong Ma; Jia Li; Hanqing Ye; Jihye Ko; Phillip D Zamore; Guangping Gao
Journal:  Mol Ther       Date:  2019-11-27       Impact factor: 11.454

2.  Adeno-Associated Virus Genome Interactions Important for Vector Production and Transduction.

Authors:  Anna C Maurer; Matthew D Weitzman
Journal:  Hum Gene Ther       Date:  2020-05       Impact factor: 5.695

3.  Conditional, inducible gene silencing in dopamine neurons reveals a sex-specific role for Rit2 GTPase in acute cocaine response and striatal function.

Authors:  Carolyn G Sweeney; Patrick J Kearney; Rita R Fagan; Lindsey A Smith; Nicholas C Bolden; Rubing Zhao-Shea; Iris V Rivera; Jenya Kolpakova; Jun Xie; Guangping Gao; Andrew R Tapper; Gilles E Martin; Haley E Melikian
Journal:  Neuropsychopharmacology       Date:  2019-07-05       Impact factor: 7.853

4.  AAV integration in human hepatocytes.

Authors:  Dhwanil A Dalwadi; Andrea Calabria; Amita Tiyaboonchai; Jeffrey Posey; Willscott E Naugler; Eugenio Montini; Markus Grompe
Journal:  Mol Ther       Date:  2021-08-28       Impact factor: 12.910

Review 5.  FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?

Authors:  Charis L Himeda; Peter L Jones
Journal:  J Pers Med       Date:  2022-05-25

6.  Human and Insect Cell-Produced Recombinant Adeno-Associated Viruses Show Differences in Genome Heterogeneity.

Authors:  Ngoc Tam Tran; Emilie Lecomte; Sylvie Saleun; Suk Namkung; Cécile Robin; Kristina Weber; Eric Devine; Veronique Blouin; Oumeya Adjali; Eduard Ayuso; Guangping Gao; Magalie Penaud-Budloo; Phillip W L Tai
Journal:  Hum Gene Ther       Date:  2022-04       Impact factor: 4.793

7.  Regulation of sclerostin by the SIRT1 stabilization pathway in osteocytes.

Authors:  Jung-Min Kim; Yeon-Suk Yang; Jun Xie; Oksun Lee; JiHea Kim; Jaehyoung Hong; Brigitte Boldyreff; Odile Filhol; Hyonho Chun; Matthew B Greenblatt; Guangping Gao; Jae-Hyuck Shim
Journal:  Cell Death Differ       Date:  2022-02-15       Impact factor: 12.067

8.  Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery.

Authors:  Yeon-Suk Yang; Jung-Min Kim; Jun Xie; Sachin Chaugule; Chujiao Lin; Hong Ma; Edward Hsiao; Jaehyoung Hong; Hyonho Chun; Eileen M Shore; Frederick S Kaplan; Guangping Gao; Jae-Hyuck Shim
Journal:  Nat Commun       Date:  2022-10-19       Impact factor: 17.694

9.  AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice.

Authors:  Jiaming Wang; Yue Zhang; Craig A Mendonca; Onur Yukselen; Khaja Muneeruddin; Lingzhi Ren; Jialing Liang; Chen Zhou; Jun Xie; Jia Li; Zhong Jiang; Alper Kucukural; Scott A Shaffer; Guangping Gao; Dan Wang
Journal:  Nature       Date:  2022-03-23       Impact factor: 69.504

10.  Satellite Subgenomic Particles Are Key Regulators of Adeno-Associated Virus Life Cycle.

Authors:  Junping Zhang; Xiangping Yu; Ping Guo; Jenni Firrman; Derek Pouchnik; Yong Diao; Richard Jude Samulski; Weidong Xiao
Journal:  Viruses       Date:  2021-06-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.